Title:
THERAPEUTIC REGIMENS OF A DEGRADER OF BRD9
Document Type and Number:
WIPO Patent Application WO/2023/009701
Kind Code:
A8
Abstract:
Methods of treating a BAF complex-related disorder, an SS18-SSX fusion protein-related disorder, a BRD9-related disorder, or cancer in a subject in need thereof are disclosed. The methods include the step of administering to the subject a regimen of an effective amount of compound S-D1 Compound S-D1, or a pharmaceutically acceptable salt thereof.
Inventors:
CHEN HUAWEI (US)
HUANG LIYUE (US)
HUANG LIYUE (US)
Application Number:
PCT/US2022/038641
Publication Date:
April 06, 2023
Filing Date:
July 28, 2022
Export Citation:
Assignee:
FOGHORN THERAPEUTICS INC (US)
International Classes:
A61K31/4035; A61K31/4353; A61K31/4375; A61K31/445; A61K31/45; A61P35/00
Attorney, Agent or Firm:
BELLIVEAU, Michael, J. (US)
Download PDF:
Previous Patent: CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND USES THEREOF
Next Patent: EYE GLASSES TO ALLEVIATE MOTION SICKNESS
Next Patent: EYE GLASSES TO ALLEVIATE MOTION SICKNESS